Related Experiment Video

Updated: Jun 8, 2026

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

Targeting karyotypic complexity and chromosomal instability of cancer cells

Anna V Roschke1, Ilan R Kirsch

  • 1Genetics Branch, Center for Cancer Research, National Cancer Institute, Building NNMC8, Room 5101, Bethesda, MD 20889-5105, USA. roschkea@mail.nih.gov

Current Drug Targets
|September 16, 2010
PubMed

Insights

Cancer cells often resist chemotherapy due to chromosomal abnormalities. Assessing these tumor-specific chromosomal states could guide the development of new drugs for aggressive cancers.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Biology

Background:

  • Many cancers exhibit chromosomal abnormalities and instability.
  • These features contribute to resistance against current chemotherapeutic agents.
  • Chromosomal instability is a hallmark of aggressive and intractable cancers.

Purpose of the Study:

  • To explore chromosomal abnormalities as potential therapeutic targets.
  • To investigate the role of chromosomal state in cancer drug resistance.
  • To guide the selection and development of novel anti-cancer drugs.

Main Methods:

  • Analysis of karyotypic abnormalities in cancer cell populations.
  • Assessment of chromosomal instability.
  • Correlation of chromosomal state with chemotherapeutic resistance.

Main Results:

  • Identified multiple karyotypic abnormalities and chromosomal instability in therapy-resistant cancers.
  • Demonstrated that these chromosomal features are tumor-specific.
  • Established a link between chromosomal state and drug response.

Conclusions:

  • Chromosomal abnormalities and instability are key features of difficult-to-treat cancers.
  • Targeting these tumor-specific chromosomal states offers a promising strategy for new cancer therapies.
  • Assessment of chromosomal state can inform personalized cancer treatment approaches.

More Related Videos

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

Assessing Specificity of Anticancer Drugs In Vitro09:39

Assessing Specificity of Anticancer Drugs In Vitro

Published on: March 23, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...